National Health Investors, Inc. (NYSE:NHI) Receives Average Rating of “Moderate Buy” from Brokerages

National Health Investors, Inc. (NYSE:NHIGet Free Report) has been assigned an average rating of “Moderate Buy” from the seven ratings firms that are currently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $73.29.

NHI has been the topic of a number of recent research reports. Bank of America began coverage on National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective on the stock. Truist Financial upped their target price on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a report on Friday, August 30th. Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and upped their target price for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Finally, StockNews.com downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th.

View Our Latest Research Report on NHI

National Health Investors Stock Down 0.2 %

NHI stock opened at $77.71 on Monday. The firm has a market cap of $3.53 billion, a PE ratio of 26.70, a PEG ratio of 5.19 and a beta of 1.05. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. National Health Investors has a one year low of $51.59 and a one year high of $86.13. The firm’s 50 day moving average price is $79.48 and its 200-day moving average price is $74.49.

National Health Investors (NYSE:NHIGet Free Report) last announced its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The firm had revenue of $63.32 million during the quarter, compared to analysts’ expectations of $67.93 million. During the same period in the previous year, the firm earned $1.08 EPS. The firm’s revenue for the quarter was up 1.7% compared to the same quarter last year. On average, equities research analysts anticipate that National Health Investors will post 4.42 EPS for the current year.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.63%. National Health Investors’s dividend payout ratio (DPR) is 123.71%.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of NHI. Quarry LP purchased a new stake in National Health Investors in the 3rd quarter worth approximately $27,000. Covestor Ltd lifted its holdings in shares of National Health Investors by 2,700.0% during the 3rd quarter. Covestor Ltd now owns 420 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 405 shares in the last quarter. Point72 DIFC Ltd acquired a new position in National Health Investors in the 3rd quarter worth $35,000. Loomis Sayles & Co. L P acquired a new position in National Health Investors in the 3rd quarter worth $38,000. Finally, International Assets Investment Management LLC acquired a new position in National Health Investors in the 2nd quarter worth $36,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Company Profile

(Get Free Report

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

See Also

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.